LRRK2 and Parkinson disease: In the second study on the G2019S mutation of the LRRK2 gene (Reinhardt et al., 2013), the investigators generated iPSC lines from PD patients with the mutation and from control individuals, and used ZFNs to correct the mutation in three of the patient-derived lines and to insert the mutation into a control iPSC line.